Regulation of NF-κB signaling by decoy oligodeoxynucleotides

被引:54
作者
Isomura, Iwao [1 ]
Morita, Akimichi [1 ]
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Geriatr & Environm Dermatol, Mizuho Ku, Nagakute, Aichi 4678601, Japan
关键词
NF-KB; tolerance; decoy oligodeoxynucleotide;
D O I
10.1111/j.1348-0421.2006.tb03827.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The nuclear factor-kappa B (NF-kappa B) plays a critical role in regulating expression of genes responsible for a wide range of cellular processes, including innate and adoptive immune responses, and pathways related to cell survival and proliferation. Based on its property as a transcription factor, NF-kappa B has been considered as a good target for the treatment of inflammatory immune diseases. To regulate gene expression, "decoy" oligodeoxynucleotides (ODNs) are ideal tools to interfere with binding of transcription factors to promoter regions in genes. Herein we review the application of NF-kappa B decoy ODNs to control inflammatory disorders and transplantation tolerance. In addition, we provide information about induction of antigen-specific peripheral tolerance by their topical application. Regulation of NF-kappa B signaling by NF-kappa B decoy ODNs might be an effective tool to control a variety of disorders caused by inflammatory immune responses.
引用
收藏
页码:559 / 563
页数:5
相关论文
共 28 条
[1]
Transfection of NFκB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts [J].
Azuma, H ;
Tomita, N ;
Kaneda, Y ;
Koike, H ;
Ogihara, T ;
Katsuoka, Y ;
Morishita, R .
GENE THERAPY, 2003, 10 (05) :415-425
[2]
NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules [J].
Baeuerle, PA ;
Baichwal, VR .
ADVANCES IN IMMUNOLOGY, VOL 65, 1997, 65 :111-137
[3]
Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[4]
Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-κB oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig [J].
Bonham, CA ;
Peng, LS ;
Liang, XY ;
Chen, ZY ;
Wang, LF ;
Ma, LL ;
Hackstein, H ;
Robbins, PD ;
Thomson, AW ;
Fung, JJ ;
Qian, SG ;
Lu, L .
JOURNAL OF IMMUNOLOGY, 2002, 169 (06) :3382-3391
[5]
Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses [J].
Caamaño, JH ;
Rizzo, CA ;
Durham, SK ;
Barton, DS ;
Raventós-Suárez, C ;
Snapper, CM ;
Bravo, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (02) :185-196
[6]
Enhanced intracellular uptake and inhibition of NF-κB activation by decoy oligonucleotide released from PLGA microspheres [J].
De Rosa, G ;
Maiuri, MC ;
Ungaro, F ;
De Stefano, D ;
Quaglia, F ;
La Rotonda, MI ;
Carnuccio, R .
JOURNAL OF GENE MEDICINE, 2005, 7 (06) :771-781
[7]
Selective blockade of NF-κB activity in airway immune cells inhibits the effector phase of experimental asthma [J].
Desmet, C ;
Gosset, P ;
Pajak, B ;
Cataldo, D ;
Bentires-Alj, M ;
Lekeux, P ;
Bureau, F .
JOURNAL OF IMMUNOLOGY, 2004, 173 (09) :5766-5775
[8]
Treatment of murine Th1-and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides [J].
Fichtner-Feigl, S ;
Fuss, IJ ;
Preiss, JC ;
Strober, W ;
Kitani, A .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :3057-3071
[9]
Genetic approaches in mice to understand Rel/NF-κB and IκB function:: transgenics and knockouts [J].
Gerondakis, S ;
Grossmann, M ;
Nakamura, Y ;
Pohl, T ;
Grumont, R .
ONCOGENE, 1999, 18 (49) :6888-6895
[10]
The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation [J].
Gerondakis, S ;
Grumont, R ;
Rourke, I ;
Grossmann, M .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (03) :353-359